Syncom Formulations (India) Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Syncom Formulations (India) Limited with three other
companies in this sector in India:
Themis Medicare Limited
sales of 1.84 billion Indian Rupees [US$25.71 million]
of which 100%
Ortin Laboratories Ltd
(1.68 billion Indian Rupees [US$23.47 million]
Lasa Supergenerics Ltd
(1.70 billion Indian Rupees [US$23.72 million]
Syncom Formulations (India) Limited reported sales of 1.87 billion Indian Rupees (US$26.13 million)
March of 2019.
increase of 17.7%
versus 2018, when the company's sales were 1.59 billion Indian Rupees.